Patients who have experienced problems with a DePuy hip replacement may be eligible to file a lawsuit and receive a settlement. Lawsuits against the hip replacement manufacturer have alleged that DePuy failed to properly warns users about the increased risk of problems from its hip replacements.
The DePuy Orthopaedics division of Johnson & Johnson could pay $4 billion to settle thousands of DePuy ASR hip replacement lawsuits, according to an article published on November 19, 2013 in the New York Times. Johnson & Johnson has already agreed to a Depuy hip settlement amount of at least $2.47 billion.
This DePuy Orthopaedics settlement will resolve approximately 8,000 DePuy lawsuits filed by patients who had to have their hip replacement surgically removed. Johnson & Johnson is currently facing nearly 12,000 DePuy lawsuits filed in federal courts and state courts in California, Illinois and New Jersey.
DePuy recalled its DePuy ASR XL Acetabular System and ASR Hip Resurfacing System hip implants in August 2010 due to an increased rate of repair surgeries among patients with those devices. Researchers concluded that the DePuy ASR and ASR XL hip replacement systems were more than twice as likely to fail within five years as other devices.
Patients with one of the recalled DePuy hip replacements may be more likely to experience loosening of the device, bone fractures or dislocation of the implant, all of which could require hip replacement surgery. Because the DePuy ASR devices are metal-on-metal hip replacements, patients may also suffer complications from metal debris that can be shed from the device through wear and tear on its metal parts, and may be at risk of metal poisoning.
If you or a loved one received a DePuy ASR or ASR XL implant, you may be eligible to file a lawsuit. To receive a free legal consultation and find out if you may be eligible for a DePuy settlement, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.